Orphazyme A/S

CIK 1764791 · other company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Orphazyme A/S.

Recent SEC filings

FiledFormAccession number
Feb 10, 2023SC 13G/A0001193125-23-031258
Sep 26, 20226-K0001193125-22-251340
Jun 29, 20226-K0001193125-22-185056
Jun 28, 202220-F0001564590-22-024528
Jun 21, 20226-K0001193125-22-177654
Jun 9, 20226-K0001193125-22-170341
May 31, 20226-K0001193125-22-163955
May 23, 20226-K0001193125-22-157473
May 18, 20226-K0001193125-22-154143
May 16, 2022NT 20-F/A0001193125-22-151726
May 16, 20226-K0001193125-22-151755
May 16, 20226-K0001193125-22-150970
May 2, 2022NT 20-F0001193125-22-137019
Apr 29, 20226-K0001564590-22-016619
Apr 29, 20226-K0001564590-22-016618
Apr 7, 20226-K0001564590-22-013752
Apr 6, 20226-K0001564590-22-013635
Apr 6, 20226-K0001564590-22-013627
Apr 4, 20226-K0001564590-22-013424
Apr 1, 20226-K0001564590-22-013084
Mar 31, 202215-12B0001193125-22-092117
Mar 31, 20226-K0001564590-22-012953
Mar 29, 20226-K0001564590-22-012064
Mar 23, 2022EFFECT9999999995-22-000701
Mar 22, 20226-K0001564590-22-011237